Update: 18.06.2024
Last week: 23 week 2024 (03.06.2024 - 09.06.2024)
Last full month: May 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 128 | 6.8% | 10.8% | -0.1 | 15 031 591 | 4.0% | 8.5% | -0.5 | 8.1% |
| MoM | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| YTD | 165 923 | 20.6% | 11.1% | 2.4 | 368 463 395 | 47.2% | 9.4% | 2.1 | -5.4% |
| MAT | 369 133 | 30.3% | 10.1% | 1.9 | 774 914 595 | 49.8% | 8.6% | 1.5 | 6.3% |
| BRAINMAX | |||||||||
| WoW | 1 126 | 5.6% | 100.0% | 0 | 4 119 858 | 2.9% | 100.0% | 0 | 5.6% |
| MoM | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| YTD | 23 678 | 42.4% | 100.0% | 0 | 85 833 124 | 53.4% | 100.0% | 0 | 42.4% |
| MAT | 53 705 | 100.3% | 100.0% | 0 | 190 870 098 | 115.1% | 100.0% | 0 | 100.3% |
| GOLDLINE PLUS | |||||||||
| WoW | 18 701 | 6.6% | 46.1% | 0.9 | 57 738 939 | 7.5% | 37.6% | 1.2 | 4.5% |
| MoM | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| YTD | 396 651 | -1.9% | 44.6% | 1.2 | 1 254 863 894 | 2.1% | 36.4% | -2.9 | -4.6% |
| MAT | 861 211 | 11.2% | 45.5% | 1.4 | 2 717 443 700 | 18.8% | 38.3% | -1 | 7.9% |
| MIGRENIUM | |||||||||
| WoW | 12 422 | 19.3% | 0.6% | 0.1 | 4 033 125 | 18.1% | 0.8% | 0.1 | 8.8% |
| MoM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| YTD | 279 672 | 1.1% | 0.6% | -0.1 | 84 119 863 | 68.6% | 0.7% | 0.2 | 14.6% |
| MAT | 644 653 | 5.4% | 0.5% | -0.1 | 156 896 462 | 41.3% | 0.6% | 0 | 17.3% |
| MODELAX-N | |||||||||
| WoW | 29 707 | 14.8% | 24.1% | 2.7 | 13 170 316 | 13.0% | 16.0% | 1.7 | 2.0% |
| MoM | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| YTD | 703 023 | 44.6% | 23.4% | 4.9 | 296 055 581 | 94.0% | 14.9% | 4.4 | 14.5% |
| MAT | 1 384 692 | 81.8% | 20.8% | 6.7 | 526 242 704 | 114.2% | 12.4% | 4.4 | 22.9% |
| REDUXIN | |||||||||
| WoW | 12 892 | 0.9% | 31.8% | -1.1 | 68 371 524 | 0.1% | 44.6% | -1.7 | 4.5% |
| MoM | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| YTD | 294 308 | -7.7% | 33.1% | -1.1 | 1 593 635 054 | 19.9% | 46.2% | 3.7 | -4.6% |
| MAT | 613 299 | 0.9% | 32.4% | -2.2 | 3 137 185 128 | 24.7% | 44.2% | 1 | 7.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 552 | 6.3% | 8.8% | 0.1 | 15 479 715 | 8.0% | 10.1% | 0.4 | 4.5% |
| MoM | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| YTD | 77 164 | 4.4% | 8.7% | 0.7 | 336 267 669 | 21.3% | 9.7% | 0.9 | -4.6% |
| MAT | 169 261 | 24.0% | 8.9% | 1.2 | 712 573 986 | 37.7% | 10.0% | 1.2 | 7.9% |
| SALVISAR | |||||||||
| WoW | 10 381 | -2.3% | 1.4% | -0.2 | 4 346 281 | -2.9% | 1.2% | -0.2 | 9.0% |
| MoM | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
| YTD | 245 794 | 2.4% | 1.4% | 0 | 97 503 460 | 26.0% | 1.3% | 0.1 | 3.0% |
| MAT | 504 180 | -13.0% | 1.2% | -0.3 | 183 858 160 | -6.2% | 1.1% | -0.3 | 7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 165 923 | 20.6% | 11.1% | 2.4 | 368 463 395 | 47.2% | 9.4% | 2.1 | -5.4% |
| BRAINMAX | 23 678 | 42.4% | 100.0% | 0 | 85 833 124 | 53.4% | 100.0% | 0 | 42.4% |
| GOLDLINE PLUS | 396 651 | -1.9% | 44.6% | 1.2 | 1 254 863 894 | 2.1% | 36.4% | -2.9 | -4.6% |
| MIGRENIUM | 279 672 | 1.1% | 0.6% | -0.1 | 84 119 863 | 68.6% | 0.7% | 0.2 | 14.6% |
| MODELAX-N | 703 023 | 44.6% | 23.4% | 4.9 | 296 055 581 | 94.0% | 14.9% | 4.4 | 14.5% |
| REDUXIN CAPS | 294 308 | -7.7% | 33.1% | -1.1 | 1 593 635 054 | 19.9% | 46.2% | 3.7 | -4.6% |
| REDUXIN FORTE | 77 164 | 4.4% | 8.7% | 0.7 | 336 267 669 | 21.3% | 9.7% | 0.9 | -4.6% |
| SALVISAR | 245 794 | 2.4% | 1.4% | 0 | 97 503 460 | 26.0% | 1.3% | 0.1 | 3.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 369 133 | 30.3% | 10.1% | 1.9 | 774 914 595 | 49.8% | 8.6% | 1.5 | 6.3% |
| BRAINMAX | 53 705 | 100.3% | 100.0% | 0 | 190 870 098 | 115.1% | 100.0% | 0 | 100.3% |
| GOLDLINE PLUS | 861 211 | 11.2% | 45.5% | 1.4 | 2 717 443 700 | 18.8% | 38.3% | -1 | 7.9% |
| MIGRENIUM | 644 653 | 5.4% | 0.5% | -0.1 | 156 896 462 | 41.3% | 0.6% | 0 | 17.3% |
| MODELAX-N | 1 384 692 | 81.8% | 20.8% | 6.7 | 526 242 704 | 114.2% | 12.4% | 4.4 | 22.9% |
| REDUXIN CAPS | 613 299 | 0.9% | 32.4% | -2.2 | 3 137 185 128 | 24.7% | 44.2% | 1 | 7.9% |
| REDUXIN FORTE | 169 261 | 24.0% | 8.9% | 1.2 | 712 573 986 | 37.7% | 10.0% | 1.2 | 7.9% |
| SALVISAR | 504 180 | -13.0% | 1.2% | -0.3 | 183 858 160 | -6.2% | 1.1% | -0.3 | 7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 128 | 6.8% | 10.8% | -0.1 | 15 031 591 | 4.0% | 8.5% | -0.5 | 8.1% |
| BRAINMAX | 1 126 | 5.6% | 100.0% | 0 | 4 119 858 | 2.9% | 100.0% | 0 | 5.6% |
| GOLDLINE PLUS | 18 701 | 6.6% | 46.1% | 0.9 | 57 738 939 | 7.5% | 37.6% | 1.2 | 4.5% |
| MIGRENIUM | 12 422 | 19.3% | 0.6% | 0.1 | 4 033 125 | 18.1% | 0.8% | 0.1 | 8.8% |
| MODELAX-N | 29 707 | 14.8% | 24.1% | 2.7 | 13 170 316 | 13.0% | 16.0% | 1.7 | 2.0% |
| REDUXIN CAPS | 12 892 | 0.9% | 31.8% | -1.1 | 68 371 524 | 0.1% | 44.6% | -1.7 | 4.5% |
| REDUXIN FORTE | 3 552 | 6.3% | 8.8% | 0.1 | 15 479 715 | 8.0% | 10.1% | 0.4 | 4.5% |
| SALVISAR | 10 381 | -2.3% | 1.4% | -0.2 | 4 346 281 | -2.9% | 1.2% | -0.2 | 9.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| BRAINMAX | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| GOLDLINE PLUS | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| MIGRENIUM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| MODELAX-N | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| REDUXIN CAPS | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| REDUXIN FORTE | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| SALVISAR | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"## [1] "BRAINMAX"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs